1,3,8-Trihydroxy-4-methyl-2,7-diprenylxanthone

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: 1,3,8-Trihydroxy-4-methyl-2,7-diprenylxanthone
• 英文别名: 1,3,8-trihydroxy-4-methyl-2,7-bis(3-methylbut-2-enyl)xanthen-9-one
• 化学式: C₂₄H₂₆O₅
• 分子量: 394.5
• InChiKey: QPSZSDVSMAQDTD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.7
• 重原子数：
  29
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  87
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• Oral compositions containing extracts of garcinia mangostana l. and related methods
  申请人：Colgate-Palmolive Company

  公开号：EP2689805A1

  公开（公告）日：2014-01-29

  Described herein are compositions comprising a combination of extracts, and methods of preparing and using the same.

  本文描述了包含提取物组合的组合物，以及制备和使用组合物的方法。
• Pharmaceutical and therapeutic compositions derived from Garcinia mangostana L plant
  申请人：Moffett Alex

  公开号：US20060105069A1

  公开（公告）日：2006-05-18

  The present invention relates to pharmaceutical, therapeutic, nutritional, cosmetic, and dermatological compositions derived from the preicarp (rind) of the Garcinia mangostana L plant and the novel extraction processes used to produce those compositions. Specifically, the present invention relates, in part, to an approximately 0.01% to about 80% mixture of a xanthone-rich mangosteen pericarp (rind) extract in novel combinations for pharmaceutical, cosmetic, therapeutic or dermatological compositions that yield surprising health benefits. Additionally, the present invention relates, in part, to novel extraction processes that result in the production of the novel compositions of the invention.

  本发明涉及药物、治疗、营养、化妆品和皮肤病组合物，这些组合物由芒果树的果皮提取。 果皮 L 植物的前果皮（果皮）中提取的药物、治疗、营养、美容和皮肤病组合物，以及用于生产这些组合物的新型提取工艺。具体而言，本发明部分涉及一种富含氧杂蒽酮的山竹果果皮提取物的约 0.01% 至约 80% 的混合物，该混合物以新颖的组合方式用于制药、美容、治疗或皮肤病组合物，可产生令人惊喜的健康益处。此外，本发明还部分涉及可生产本发明新型组合物的新型提取工艺。
• PHARMACEUTICAL AND THERAPEUTIC COMPOSITIONS DERIVED FROM GARCINIA MANGOSTANA L PLANT
  申请人：Renaissance Herbs, Inc.

  公开号：EP1824442A1

  公开（公告）日：2007-08-29
• ORAL COMPOSITIONS CONTAINING EXTRACTS OF GARCINIA MANGOSTANA L. AND RELATED METHODS
  申请人：Colgate-Palmolive Company

  公开号：EP2506933A1

  公开（公告）日：2012-10-10
• [EN] PHARMACEUTICAL AND THERAPEUTIC COMPOSITIONS DERIVED FROM GARCINIA MANGOSTANA L PLANT<br/>[FR] COMPOSITIONS PHARMACEUTIQUES ET THERAPEUTIQUES DERIVEES DE GARCINIA MANGOSTANA L.
  申请人：RENAISSANCE HERBS INC

  公开号：WO2006055688A1

  公开（公告）日：2006-05-26

  [EN] The present invention relates to pharmaceutical, therapeutic, nutritional, cosmetic, and dermatological compositions derived from the preicarp (rind) of the Garcinia mangostana L plant and the novel extraction processes used to produce those compositions. Specifically, the present invention relates, in part, to an approximately 0.01% to about 80% mixture of a xanthone-rich mangosteen pericarp (rind) extract in novel combinations for pharmaceutical, cosmetic, therapeutic or dermatological compositions that yield surprising health benefits. Additionally, the present invention relates, in part, to novel extraction processes that result in the production of the novel compositions of the invention.
  [FR] L'invention concerne des compositions pharmaceutiques, thérapeutiques, nutritionnelles, cosmétiques et dermatologiques dérivées du péricarpe (écorce) de Garcinia mangostana L., et de nouveaux procédés d'extraction utilisés pour produire ces compositions. Spécifiquement, l'invention concerne un mélange renfermant environ 0,01 % à environ 80 % d'un extrait du péricarpe (écorce) de mangoustan riche en xanthone, dans de nouvelles combinaisons destinées à des compositions pharmaceutiques, cosmétiques, thérapeutiques ou dermatologiques bénéfiques pour la santé. L'invention concerne en outre de nouveaux procédés d'extraction permettant de produire les nouvelles compositions de l'invention.